EXCHANGE AGREEMENTExchange Agreement • March 1st, 2024 • Jaguar Health, Inc. • Pharmaceutical preparations • Utah
This Exchange Agreement (this “Agreement”) is entered into as of March 1, 2024 (the “Effective Date”) by and between Streeterville Capital, LLC, a Utah limited liability company (“Investor”), and Jaguar Health, Inc., a Delaware corporation (“Company”). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Royalty Interest (as defined below).
EXCHANGE AGREEMENTExchange Agreement • March 1st, 2024 • Jaguar Health, Inc. • Pharmaceutical preparations • California
This Exchange Agreement (this “Agreement”) is entered into as of February 27, 2024 (the “Effective Date”) by and between [________] (“Investor”), and Jaguar Health, Inc., a Delaware corporation (the “Company”). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Securities Purchase Agreement (as defined below).
